An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

NCT01336647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediculosis

Interventions

DRUG: Group A - Low-Dose Ha44 0.37% w/w
DRUG: Group B - High Dose Ha44 Gel 0.74% w/w
DRUG: Group C - Placebo

Sponsor

Dr. Reddy's Laboratories Limited